From the Research
Insulin Dosage for Hyperglycemia using Novolog (Insulin Aspart) 70/30
- The provided studies do not directly address the specific insulin dosage for a patient with hyperglycemia using Novolog (insulin aspart) 70/30 1, 2, 3, 4, 5.
- However, study 2 mentions that for patients receiving continuous tube feedings, the recommended dose is 0.6-1.0 U/kg of premixed 70/30 (NPH/regular) insulin every 8 hours.
- Study 4 compares the efficacy of 70/30 biphasic insulin with a glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy, but does not provide a specific dosage for Novolog (insulin aspart) 70/30.
- Study 5 examines the impact of an aspart insulin protocol for treatment of hyperglycemia, but uses a different insulin regimen (detemir-aspart) and does not provide a specific dosage for Novolog (insulin aspart) 70/30.
General Insulin Management
- Study 3 recommends basal, prandial, and correction dosing as the best methods for insulin administration in hospitalized patients.
- Study 2 suggests that the dose of basal insulin should be adjusted based on the patient's medical condition, with a starting dose of 0.5 U/kg for the average patient.
- Study 5 demonstrates the safety and efficacy of an aspart insulin protocol in the emergency department and hospital settings, but does not provide specific guidance on Novolog (insulin aspart) 70/30 dosage.